Skip to content

Advertisement

Open Peer Review Reports for: Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
1 Jun 2016 Submitted Original manuscript
22 Sep 2016 Reviewed Reviewer Report - Shanmugam Panneer Selvam
28 Sep 2016 Reviewed Reviewer Report - Le Meng
25 Oct 2016 Author responded Author comments - Xue Wu
Resubmission - Version 2
25 Oct 2016 Submitted Manuscript version 2
1 Nov 2016 Reviewed Reviewer Report - Le Meng
13 Feb 2017 Author responded Author comments - Xue Wu
Resubmission - Version 3
13 Feb 2017 Submitted Manuscript version 3
Publishing
15 Feb 2017 Editorially accepted
21 Feb 2017 Article published 10.1186/s12885-017-3145-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement